https://www.pharmaceutical-technology.com/analyst-comment/esc-2025-higher-leg-muscle-scores-reduce-cardiovascular-risk/ 2025-09-01T14:36:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/santhera-ikris-dmd/ 2025-09-01T09:32:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-wayrilz-btk-inhibitor/ 2025-09-22T01:53:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/interviews/vpag-stalemate-threatens-to-exclude-innovative-medicines-from-the-uk/ 2025-09-07T23:47:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/teva-saxenda-generic-fda-approval-launch/ 2025-08-29T15:15:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chickenpox-jab-to-be-included-on-englands-childhood-vaccination-programme/ 2025-08-29T13:28:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/outlooks-wet-amd-candidate-hit-with-second-fda-snub-in-two-years/ 2025-08-29T10:48:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/health-canada-noc-abbvie-upadacitinib/ 2025-08-29T10:03:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhra-gsk-antibiotic-utis/ 2025-08-29T07:59:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/podcast-migration-of-clinical-studies/ 2025-08-28T17:05:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/four-drugs-first-bispecific-adc-approval/ 2025-09-15T12:12:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-enlists-srrna-developer-replicate-in-550m-deal/ 2025-08-28T15:04:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/cell-and-gene-therapies-on-correction-course-but-not-sinking/ 2025-08-28T11:22:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-mrna-vaccines-for-new-covid-19-season-amid-political-tension/ 2025-09-28T09:53:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ai-psychosis-co-creating-delusions-with-technology/ 2025-08-28T11:07:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/pci-pharma-services-completes-acquisition-of-ajinomoto-althea/ 2025-08-28T09:50:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hope-biosciences-multiple-sclerosis/ 2025-08-28T09:28:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/excellthera-zemcelpro-cell-therapy/ 2025-08-28T07:53:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amylyx-culls-rare-neurological-disorder-programme-after-trial-failure/ 2025-08-27T15:40:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/2024-growth-recovery-top-biopharma-companies/ 2025-08-27T13:32:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-eyes-orforglipron-approval-after-phase-iii-diabetes-trial-success/ 2025-08-27T10:41:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/opadry-complete-tablet-coating-system-by-colorcon-now-45-years-old/ 2025-09-02T11:07:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-bans-ixchiq-in-the-us-sending-valneva-shares-plummeting/ 2025-08-26T16:06:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-the-latest-frewitt-flexmills-are-crushing-the-opposition/ 2025-08-26T15:38:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gileads-yeytuo-approved-in-eu-boosting-its-blockbuster-potential/ 2025-08-26T10:43:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-signs-gilgamesh-bretisilocin/ 2025-08-26T10:22:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genentech-construction-facility-north-carolina/ 2025-08-26T08:28:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/moderna-covid-19-vaccine-approval/ 2025-08-25T11:10:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/daiichi-sankyo-astrazenecas-datroway-china/ 2025-08-25T09:08:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/animal-testing-alternatives-to-dominate-but-not-overnight/ 2025-08-22T16:06:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eu-us-trade-deal-pharmaceutical-tariffs/ 2025-08-26T09:57:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bavarian-nordic-boosts-2025-guidance-as-takeover-offer-looms/ 2025-08-22T15:07:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/navigating-regulatory-change-in-apac-insights-from-the-upcoming-biosecure-act-webinar/ 2025-08-22T10:29:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ionis-donidalorsen-hae/ 2025-08-22T09:54:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gileads-kite-scoops-in-vivo-car-t-specialist-interius-for-350m/ 2025-08-27T15:12:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/magazine-big-biopharma-take-on-the-adc-challenge/ 2025-08-22T08:11:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/andelyn-amplo-aav-gene/ 2025-08-22T08:02:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/padcev-keytruda-approved-for-nhs-use/ 2025-08-21T16:04:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/advancing-rare-disease-trials-by-overcoming-patient-recruitment-challenges/ 2025-08-21T15:19:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-signs-2bn-incumbency-deal-at-cdmo-fujifilms-new-hub/ 2025-08-21T14:59:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novos-facility-issues-delay-fda-decisions-on-regenerons-eylea-hd/ 2025-08-21T10:24:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/keros-orphan-drug-status-dmd/ 2025-08-21T09:56:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-anges-drug-substance-manufacturing/ 2025-08-21T08:04:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-battles-another-paxlovid-lawsuit-from-enanta/ 2025-08-20T15:53:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/madrigal-wins-european-mash-approval-as-novo-rivalry-looms/ 2025-08-20T11:19:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-systimmune-breakthrough-nsclc-drug/ 2025-08-20T10:15:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ptc-vatiquinone-fda-rejection-friedreich-ataxia/ 2025-08-20T10:11:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ashibio-vantictumab-rare-bone-disorder/ 2025-08-20T08:23:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/viking-obesity-pill-phase-ii-results/ 2025-08-19T17:12:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/trade-offs-abound-as-big-pharma-makes-direct-to-consumer-transition/ 2025-08-19T15:13:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/accelerating-healthcare-marketing-how-a-data-driven-strategy-can-transform-lead-generation/ 2026-01-11T10:48:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/data-points-to-potential-for-patient-centricity-in-rare-disease-trial-success/ 2025-08-19T12:55:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/csl-slashes-15-of-workforce-and-offshoots-vaccine-division/ 2025-08-19T10:50:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/santen-remegen-retinal-disease-injection/ 2025-08-19T10:12:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-ec-ogsiveo-desmoid-tumours/ 2025-08-19T07:53:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-ingelheim-marks-retinal-disease-push-with-327m-licensing-deal/ 2025-08-18T14:58:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/accelerating-diagnosis-and-drug-development-with-better-managed-datasets/ 2025-08-18T13:50:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/novel-software-solutions-can-ease-transition-in-an-age-of-clinical-supply-chain-upheaval/ 2025-08-18T11:11:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-papzimeos-as-first-therapy-for-hpv-caused-airway-disease/ 2025-08-18T10:42:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/wegovy-glp-1ra-fda-mash-approval/ 2025-08-18T14:03:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aquestive-funding-agreement-anaphylm/ 2025-08-18T09:57:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-orphan-status-ema-rilzabrutinib/ 2025-08-18T08:50:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/addressing-inefficiencies-in-clinical-trial-data-management/ 2025-08-18T11:01:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-tonix-tonmya-fibromyalgia/ 2025-08-18T08:02:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-tzield-mhra-approval-type-1-diabetes/ 2025-08-15T13:28:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/trump-targets-bolstering-of-us-emergency-drug-reserve/ 2025-08-15T13:19:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-pharmacist-says-eli-lillys-mounjaro-price-hike-a-shock/ 2025-08-15T14:28:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ai-improving-ipf-care/ 2025-08-15T09:20:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/cdmo-insights-podcast-series-our-experience-is-your-strength-episode-4-commercial-launch/ 2025-08-15T08:52:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/infectious-disease-screening-sud/ 2025-08-15T11:11:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-seeks-more-gpcr-weight-loss-drugs-in-1-3bn-research-deal/ 2025-08-14T16:32:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-chikungunya-cases-ixchiq-safety-concerns/ 2025-08-14T15:32:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/us-eosinophilic-oesophagitis-market-2030/ 2025-08-14T15:03:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/basilea-secures-rights-to-venatorxs-antibiotic-for-complicated-utis/ 2025-08-14T10:45:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/apertura-multiple-agreements-tfr1-capx-technology/ 2025-08-14T08:05:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-accused-of-bribing-providers-to-prescribe-glp-1ra-drugs/ 2025-08-13T14:30:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/insmed-wins-fda-approval-for-future-blockbuster-brinsupri/ 2025-08-13T14:32:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/puretech-celea-therapeutics-respiratory-spinoff/ 2025-08-13T10:46:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amphastar-anji-license-agreement-peptides/ 2025-08-13T10:33:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-to-solve-the-big-challenges-of-cell-and-gene-therapy-manufacturing/ 2025-08-20T13:22:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/a-new-way-forward-in-ovarian-cancer-why-synthetic-imscs-could-change-the-paradigm/ 2025-08-13T10:14:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-north-chicago-api-production/ 2025-08-13T08:31:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/podcast-us-tariff-news-and-q2-earnings-influence-pharma-trends/ 2025-08-13T16:41:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-and-gsk-drive-south-koreas-drug-licensing-activity/ 2025-08-12T16:37:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pharmather-ketamine-fda-approval/ 2025-08-12T16:24:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/prasads-shock-fda-return-reignites-regulatory-uncertainty/ 2025-08-12T10:18:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sartorius-3m-minority-share-nanotein/ 2025-08-13T09:35:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fosun-645m-licensing-expedition-respiratory-drug/ 2025-08-12T08:43:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/weightwatchers-shuns-compounded-semaglutide-amid-fda-rules/ 2025-08-11T16:34:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/lilly-confidential-reimbursement-germany/ 2025-08-11T15:25:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/interviews/uncertainty-around-tariffs-is-a-disincentive-for-pharma-onshoring-in-the-us/ 2025-08-11T13:57:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsks-oral-antibiotic-for-gonorrhoea-set-for-fda-review/ 2025-08-11T10:38:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biostars-angel-stem-cell-therapy-japan-autism/ 2025-08-11T10:23:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-hernexos-fast-track-fda-approval/ 2025-08-11T10:16:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/arvinas-vepdegestrant-nda-fda-acceptance-breast-cancer/ 2025-08-11T08:28:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/podcast-epro-explained/ 2025-08-08T19:06:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/epipen-patent-expiry-opens-new-era-for-innovation/ 2025-08-08T16:36:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-yeztugo-q2-results/ 2025-08-08T15:32:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uncertainty-looms-over-fda-scheme-to-boost-us-drug-manufacturing/ 2025-08-08T15:30:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/epkinly-breaks-ground-in-phase-iii-fl-trial/ 2025-08-08T11:00:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-removes-ixchiq-partial-pause-but-tightens-vaccines-use/ 2025-08-08T10:35:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/maxona-seeks-fda-approval-pain-relief-therapy-max-001/ 2025-08-08T10:32:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/podcast-why-the-healthcare-industry-needs-linked-data/ 2025-08-11T08:19:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cormedix-acquires-melinta-300m/ 2025-08-08T08:26:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mounjaro-and-zepbound-fuel-strong-q2-growth-for-eli-lilly/ 2025-08-07T16:20:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/why-liverpools-wirtz-is-causing-concern-at-big-pharma-company-bayer/ 2025-08-07T18:16:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rfk-jr-mrna-funding-halt/ 2025-09-02T03:18:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astria-therapeutics-navenibart-kaken-hae/ 2025-08-07T08:56:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/top-seven-considerations-when-selecting-primary-packaging-for-injectable-drugs/ 2025-08-07T08:36:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jazz-pharma-fda-diffuse-midline-glioma-therapy/ 2025-08-07T08:00:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/teva-ajovy-becomes-first-migraine-prevention-drug-approved-for-children/ 2025-08-06T15:58:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisks-diabetes-and-weight-loss-drug-sales-growth-decelerates/ 2025-08-06T11:10:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fresenius-licensing-deal-polpharmas-vedolizumab-biosimilar/ 2025-08-06T09:19:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-files-14-lawsuits-unapproved-semaglutide-drugs/ 2025-08-06T08:24:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-shares-rise-3-after-upping-profit-forecast-for-2025/ 2025-08-05T15:50:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/health-on-the-brink-africa-in-the-wake-of-us-aid-cuts-podcast/ 2025-09-05T13:23:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsks-world-first-gonorrhoea-vaccine-launched-in-england/ 2025-08-05T10:46:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-china-tensions-apac-biotech-impact/ 2025-08-06T16:08:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gates-foundation-2-5bn-womens-health/ 2025-08-05T10:31:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/new-us-eu-trade-deal-tariffs-ends-pharmas-geopolitical-immunity/ 2025-08-05T10:29:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/cdmo-insights-podcast-series-our-experience-is-your-strength-episode-3-clinical-forecasting-packaging-distribution/ 2025-08-05T09:21:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/pediatric-research-how-to-fix-a-clinical-trial-system-built-for-adults/ 2025-08-05T08:35:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/agios-pyrukynd-gains-sfda-approval-thalassemia/ 2025-08-05T07:47:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pharma-ceos-downplay-impact-of-tariffs-amid-rising-cost-concerns/ 2025-08-04T16:03:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sandoz-evotec-biologics-biosimilar-manufacturing/ 2025-08-04T15:20:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/atombeat-bioduro-peptide-drug-discovery/ 2025-08-04T10:40:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/manufacturing-issues-at-novo-facility-disrupt-regeneron-drug-review/ 2025-08-07T14:05:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/arrowhead-hypertriglyceridemia-rights-china/ 2025-08-04T08:01:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/europes-cannabis-pharmaceuticals-market-matures-amid-cautious-investment/ 2025-07-27T20:21:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/moderna-q2-results-2025-cost-cutting/ 2025-08-01T17:15:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lillys-mounjaro-shows-cardiovascular-gains-but-analysts-underwhelmed/ 2025-08-01T11:05:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/supernus-sage-neuropsychiatric-portfolio/ 2025-08-01T10:09:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/cell-and-gene-therapy-market-outlook-strong-despite-technical-challenges/ 2025-10-15T10:44:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/beone-btk-degrader-prime/ 2025-08-01T08:00:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/trump-doubles-down-on-most-favored-nation-plan-to-target-drug-prices/ 2025-08-01T11:55:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/george-tidmarsh-temporary-fda-cber-director/ 2025-07-31T16:53:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/targeting-energy-expenditure-the-next-wave-of-obesity-drugs/ 2025-07-31T19:37:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dupixent-sales-spur-sanofi-growth-but-profits-fall-short/ 2025-07-31T15:56:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dr-falk-pharma-allianthera-agreement-atb102/ 2025-07-31T10:46:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/african-countries-plan-shift-to-healthcare-funding-autonomy-amid-aid-cuts/ 2025-07-31T10:34:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/meet-the-company-on-a-mission-to-rewrite-the-cell-therapy-paradigm-from-south-texas/ 2025-08-07T12:21:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/viridian-kissei-veligrotug-vrdn-003/ 2025-07-31T08:37:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/farxiga-and-jardiance-pose-affordability-issues-says-maryland-drug-board/ 2025-07-30T22:26:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/prasads-fda-exit-may-accelerate-cell-and-gene-therapy-approvals/ 2025-07-30T16:56:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-q2-results-speciality-medicines/ 2025-07-30T11:36:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-shares-plummet-as-2025-guidance-is-cut-overshadowing-new-ceo/ 2025-07-30T11:41:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/virocell-avencell-car-t-therapy/ 2025-08-06T09:29:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/metriopharm-orphan-drug-status-ema-mp1032/ 2025-07-30T08:36:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/msd-shares-drop-5-amid-plans-for-3bn-cost-cutting-strategy/ 2025-07-29T16:03:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/south-korea-emerges-2025-licensing-hub-growth-deals/ 2025-07-29T13:09:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bristol-myers-squibb-bain-capital-newco/ 2025-07-29T11:30:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-instils-15-tariff-rate-on-eu-for-pharmaceutical-products/ 2025-07-29T10:45:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alfasigma-sets-stage-for-jyseleca-in-axspa-after-phase-iii-win/ 2025-07-29T10:53:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/re-vana-boehringer-collaborate-eye-therapies/ 2025-07-29T10:23:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sarepta-allowed-continue-us-elevidys-shipments/ 2025-07-29T09:00:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ascendis-skytrofa-fda-approval-ghd/ 2025-07-29T08:46:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/hs-market-7mm-2034/ 2025-07-28T16:09:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-wins-positive-european-approval-opinion-for-twice-yearly-hiv-injection/ 2025-07-28T10:04:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-linked-data-can-unlock-the-full-potential-of-healthcare-research/ 2025-07-28T13:17:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofis-sarclisa-ec-approval-multiple-myeloma/ 2025-07-28T09:19:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hengrui-pharma-gsk-medicines-therapeutic/ 2025-07-28T08:03:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/synthetic-rescue-insmed-explores-a-new-frontier-in-genetic-therapeutics/ 2025-07-27T17:25:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pharma-critical-french-drug-pricing-reforms-pending-ceps-report/ 2025-07-25T16:33:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-india-fta-poised-to-benefit-medtech-and-pharma/ 2025-07-25T15:10:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chmp-rejects-elevidys-latest-setback-sarepta/ 2025-07-25T14:30:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/why-the-ai-hype-isnt-the-whole-story-lets-focus-on-the-benefits/ 2025-07-25T14:13:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-promise-and-challenges-of-the-unified-study-definition-model-usdm/ 2025-07-25T14:11:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-3sbio-licensing-deal-ssgj-707/ 2025-07-25T10:59:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/blenrep-combinations-approved-eu/ 2025-07-25T08:22:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/apnimed-sleep-apnoea-second-phase-iii/ 2025-07-24T11:26:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-wegovy-patent-battle-viatris/ 2025-07-24T15:23:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kling-bio-sanofi-partner-antibodies-epitopes/ 2025-07-24T10:26:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-ich-e6-r3-is-changing-clinical-trials/ 2025-10-08T11:55:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/exploring-ai-powered-cell-simulations-and-the-launch-of-the-worlds-first-virtual-lab/ 2025-07-24T09:04:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssens-darzalex-ec-approval-smm-treatment/ 2025-07-24T08:46:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-enacts-law-decentralise-manufacture-personalised-treatments/ 2025-07-31T11:58:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-50bn-us-investment-plans-2030/ 2025-07-23T11:09:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-acquire-vicebios-for-1-15bn-upfront/ 2025-07-23T08:03:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/johnson-johnson-seeks-fda-approval-icotrokinra/ 2025-07-22T10:22:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sarepta-halts-elevidys-shipments-following-fda-pressure/ 2025-07-22T10:08:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biogen-invest-2bn-research-triangle-park/ 2025-07-22T08:13:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/quantum-leap-or-quantum-hype/ 2025-07-21T15:48:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/life-sciences-vc-omega-funds-closes-647m-funding-round/ 2025-07-21T15:22:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sarepta-refuses-pull-gene-therapy-despite-fda/ 2025-07-22T09:23:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/five-considerations-when-scaling-up-mabs-in-partnership-with-a-cdmo/ 2025-07-21T11:24:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/cdmo-insights-podcast-series-our-experience-is-your-strength-episode-2-gene-therapy-fill-finish/ 2025-07-21T13:29:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-blueprint-medicines-acquisition/ 2025-07-21T10:31:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fangzhou-novo-nordisk-chronic-disease/ 2025-07-21T09:08:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhra-approves-needle-free-adrenaline-nasal-spray-for-anaphylaxis/ 2025-07-18T15:27:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsks-blenrep-faces-setback-as-fda-cancer-committee-votes-against-approval/ 2025-07-18T15:31:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astellas-kised-korean-pharmaceutical/ 2025-07-18T09:57:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/adcs-rise-milliporesigma-lonza-biontech-cmos-fda/ 2025-07-18T09:20:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-fda-approval-prefilled-syringe-shingrix/ 2025-07-18T08:28:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/can-rare-disease-research-in-the-us-thrive-under-the-new-administration/ 2025-07-17T19:56:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/rare-pediatric-disease-designation-impact-drug-approvals/ 2025-07-17T14:22:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sarepta-therapeutics-500-jobs-restructuring/ 2025-07-17T11:11:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/thermo-fisher-sanofis-steriles-site-us/ 2025-07-17T08:25:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pepfar-funding-protection-offers-hope-for-people-living-with-hiv/ 2025-07-16T14:21:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-government-targets-manufacturing-as-it-eyes-41bn-life-science-sector-growth/ 2025-07-16T14:13:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsks-blenrep-us-comeback-hindered-by-eye-safety-concerns/ 2025-07-16T11:05:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/why-global-3pl-providers-are-essential-to-easing-supply-chain-challenges/ 2025-07-16T10:41:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/navamedic-dne-pharma-acquisition/ 2025-07-16T10:17:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/acumen-jcr-brain-delivery-therapy-alzheimers/ 2025-07-16T08:05:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sino-biopharma-spends-951m-to-acquire-china-based-lanova-medicines/ 2025-07-15T14:44:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/otsuka-cantargias-can10-autoimmune-diseases/ 2025-07-15T14:14:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vertex-nhs-sign-reimbursement-agreement/ 2025-07-15T10:58:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/leo-pharma-secures-rights-to-boehringers-spevigo-for-105m/ 2025-07-15T10:43:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/health-canada-extendevkeeza-approval/ 2025-07-15T08:46:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/who-endorses-gileads-yeztugo-for-hiv-prevention/ 2025-07-14T14:46:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/scaling-smart-how-small-pharma-companies-can-build-resilient-supply-chains/ 2025-07-14T14:36:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/illimis-funding-alzheimers-therapeutics/ 2025-07-14T14:23:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-eyes-fda-label-expansion-for-rsv-vaccine-arexvy-to-include-younger-patients/ 2025-07-14T10:45:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ultragenyx-complete-response-letter-ux111/ 2025-07-14T10:34:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-msds-doravirine-islatravir-nda/ 2025-07-14T08:01:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-beone-medicines-tevimbra/ 2025-07-11T13:57:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-complete-response-letters/ 2025-07-11T13:10:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/real-world-evidence-as-a-strategic-access-lever-in-rare-disease-drug-development/ 2025-07-15T13:33:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-unsustainability-of-clinical-trials-and-need-for-transformative-change/ 2025-07-28T08:45:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/igi-abbvie-licensing-cancer-autoimmune/ 2025-07-11T07:38:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/modular-manufacturing-the-key-to-unlocking-mrna-expansion/ 2025-07-11T09:32:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-breakthrough-therapy-designation-tsnd-201/ 2025-07-10T15:06:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/targeted-protein-degraders-solubility-bioavailability/ 2025-07-10T15:28:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/global-oncology-cell-therapy-market-25bn-2031/ 2025-07-10T12:49:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-to-remain-a-top-cdmo-in-adc-led-oncology/ 2026-02-13T12:11:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lupin-zentiva-biosimilar-certolizumab-pegol/ 2025-07-10T09:54:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-verona-pharma-10bn/ 2025-07-10T07:57:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cto-east-coast-2025-ai-can-speed-up-all-parts-of-clinical-trial-ecosystem/ 2025-07-10T10:04:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/trumps-200-tariff-threat-could-send-shockwaves-through-pharma-supply-chains/ 2025-07-15T14:34:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/niagen-bioscience-licence-deal-pd-therapy/ 2025-07-09T12:29:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jcr-pharmaceuticals-alexion-just-aav-gene-therapy-platform/ 2025-07-31T11:57:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cto-east-coast-2025-navigating-shifting-regulatory-environment-hinges-on-close-alignment/ 2025-07-09T08:56:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/research-warns-rising-hiv-cases-africa-global-funding-cuts/ 2025-07-09T08:43:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/swissmedic-ifinwil-paediatric-patients-neuroblastoma/ 2025-07-09T07:57:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chugai-gero-antibody-treatments/ 2025-07-08T13:33:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/leading-medical-groups-sue-rfk-jr-and-hhs-over-hostile-vaccine-policies/ 2025-07-08T10:32:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pulmonary-arterial-hypertension-market-7mm-2034/ 2025-07-08T09:42:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/swissmedic-novartis-malaria-medicine-babies/ 2025-07-08T09:04:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-efimosfermin-alfa-boston-pharmaceuticals/ 2025-07-08T07:43:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-kalvistas-ekterly-hereditary-angioedema/ 2025-07-07T13:30:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-eyes-prostate-cancer-label-expansion-for-akeega/ 2025-07-07T10:59:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/doh-childrens-national-cell-gene-therapies/ 2025-07-09T16:11:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alembic-pharmaceuticals-utility-therapeutics/ 2025-07-07T08:55:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/cdmo-insights-podcast-series-our-experience-is-your-strength-episode-1-formulation/ 2025-07-07T08:17:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/five-lessons-from-biopharma-companies-data-transformation-journeys/ 2025-07-04T15:09:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/modella-ai-astrazeneca-cancer-clinical-development/ 2025-07-04T14:31:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-imfinzi-approved-in-europe-for-muscle-invasive-bladder-cancer/ 2025-07-04T14:02:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/big-pharma-braces-for-revenue-headwinds-as-patent-expiries-loom/ 2025-07-04T11:05:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biocon-denosumab-biosimilars-eu-marketing/ 2025-07-04T10:28:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/brii-biosciences-joincare-group-agreement/ 2025-07-04T08:00:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/theratechnologies-shares-surge-25-amid-254m-future-pak-takeover/ 2025-07-03T14:53:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-government-reveals-10-year-plan-for-nhs/ 2025-07-03T14:10:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bioversys-shionogi-ansamycin-leads/ 2025-07-03T13:55:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/pharmacovigilance-through-data-driven-solutions/ 2025-07-17T15:57:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/regeneron-nabs-dosing-edge-with-lynozyfics-fda-approval-in-multiple-myeloma/ 2025-07-03T10:44:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ligand-lnhc-merger-chro/ 2025-07-03T10:17:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/navigating-the-ai-regulatory-maze-why-91-of-life-sciences-professionals-feel-lost/ 2025-08-01T10:58:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/podcast-the-importance-of-social-determinants-of-health/ 2025-07-07T14:24:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-dizals-zegfrovy-adults-nsclc/ 2025-07-03T08:21:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/protecting-patients-data-vital-uk-single-health-record-system/ 2025-07-03T08:26:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/analysis-shows-yeztugo-approval-a-momentous-step-for-hiv-prevention/ 2025-07-02T15:13:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-invests-25m-adagene/ 2025-07-02T14:01:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/trump-tax-bill-estimated-to-cut-medicaid-spend-by-1trn-passes-us-senate/ 2025-07-02T10:56:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vertex-wins-european-approval-for-alyftrek-bolstering-cystic-fibrosis-stronghold/ 2025-07-02T10:08:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-springworks-acquisition/ 2025-07-02T10:03:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/cell-and-gene-therapy-the-vital-role-of-logistics/ 2025-07-04T10:32:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/uruguay-first-regulatory-agency/ 2025-07-02T09:28:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-jazz-pharmaceuticals-ziihera/ 2025-07-02T08:21:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/oncternal-sells-assets-for-up-to-68m-and-calls-it-quits/ 2025-07-01T14:55:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofis-riliprubart-orphan-drug-japan/ 2025-07-01T13:09:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/eus-pharma-package-falls-short-of-europes-goal-of-global-competitiveness/ 2025-08-20T06:15:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-buys-2-1bn-capstan-adding-new-in-vivo-car-t-to-pipeline/ 2025-07-02T09:21:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/piramal-pharma-90m-expand-us-sites/ 2025-07-01T10:34:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-takedas-gammagard-liquid-erc/ 2025-07-01T08:31:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/who-accuses-china-of-withholding-covid-19-genetic-data/ 2025-06-30T16:25:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/us-trade-tariffs-and-the-potential-impact-on-pharma-supply-chains/ 2025-06-30T14:35:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vetter-pharma-285m-clinical-manufacturing-site/ 2025-06-30T13:47:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ckd-anemia-market-7mm-2034/ 2025-06-30T12:34:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-removes-safety-programme-for-car-t-therapies-to-boost-uptake/ 2025-07-02T09:10:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sobi-fda-approval-gamifant-treat-hlh-mas/ 2025-06-30T09:32:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/torrent-pharmaceuticals-stake-jb-pharma/ 2025-06-30T07:26:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-label-updates-bms/ 2025-07-02T09:19:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ai-drug-discovery-hypothetical-reality/ 2025-06-27T12:48:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/viatris-china-approval-yupelri-copd/ 2025-06-27T10:40:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-teams-up-with-weightwatchers-in-latest-telehealth-push/ 2025-06-27T10:31:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/why-cant-the-us-figure-out-weight-loss-drug-prices/ 2025-06-27T09:36:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/porton-advanced-eva-pharma-cell-therapies/ 2025-06-27T08:40:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vor-bio-back-from-brink-with-autoimmune-drug-deal-rising-to-4bn/ 2025-06-26T15:49:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biocitys-sc0062-btd-nmpa/ 2025-06-26T14:53:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/innovation-in-focus-highlights-from-the-two-day-london-biotechnology-show-2025/ 2025-06-26T11:05:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-steps-up-with-1-25bn-gavi-vaccine-pledge-as-us-funding-disappears/ 2025-06-26T10:41:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-fda-amyvid-label-update/ 2025-06-26T10:31:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-ai-and-machine-learning-are-transforming-drug-discovery/ 2025-06-26T10:58:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-regulus-therapeutics-acquisition/ 2025-06-26T08:25:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-eyes-kymeras-adhesive-cancer-drug-in-750m-deal/ 2025-06-25T16:05:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/future-vaccine-oversight-cdc-firings/ 2025-06-25T15:30:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/how-will-rfk-jrs-american-dream-for-vaccines-play-out/ 2025-06-25T15:13:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/ehds-regulation-will-depend-on-strong-patient-confidence/ 2025-06-25T15:11:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-benlysta-autoinjector-lupus-nephritis/ 2025-06-25T14:03:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ge-healthcares-pet-imaging-agent-gains-alzheimers-label-expansion/ 2025-06-25T10:37:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/medera-novoheart-mini-heart-models/ 2025-06-25T10:23:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/alzheimers-r-d-resurgence-acquisitions/ 2025-06-25T09:15:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/revolution-medicines-royalty-pharma-rason-inhibitors/ 2025-06-25T08:23:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-sanofi-regenerons-dupixent/ 2025-06-25T07:57:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/excellence-awards/featured-company/2025-i3-membrane/ 2025-12-31T15:37:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/overcoming-technical-challenges-in-gene-therapy-product-fill-finish-operations/ 2025-06-24T14:07:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/zambon-chinese-regulatory-authority-fluimucil-iv/ 2025-06-24T13:18:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/navamedic-agreement-acquire-dne-pharma/ 2025-06-24T10:19:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hims-hers-shares-plummet-35-as-novo-nordisk-pulls-partnership-plug/ 2025-06-24T09:58:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/interviews/fda-genai-reviews-hinge-clarity-dossiers/ 2025-06-24T08:49:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-astrazeneca-daiichi-datroway-nsclc/ 2025-06-24T08:39:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bayers-eylea-market-grip-set-to-slip-as-alvotech-biosimilar-closes-in/ 2025-06-23T10:58:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/harbour-biomed-otsuka-t-cell-therapy/ 2025-06-23T10:25:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/bridging-the-gap-a-comprehensive-approach-to-social-determinants-of-health/ 2025-06-23T10:12:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-argenx-cidp-treatment/ 2025-06-23T08:00:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/from-discovery-to-delivery-making-therapies-reach-patients-faster/ 2025-06-20T14:44:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/madrigal-poised-to-enter-european-mash-market-after-chmp-endorsement/ 2025-06-20T15:04:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/london-biotechnology-show-2025-novo-nordisk-harnesses-ai-ml-to-accelerate-drug-development-landscape/ 2025-06-20T13:44:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/podcast-uses-of-blockchain-in-healthcare/ 2025-12-08T06:06:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-ribociclib-canada/ 2025-06-20T12:52:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-cell-and-gene-therapy-director-exit-increases-volatility-for-sector/ 2025-07-02T09:09:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nsw-government-life-changing-therapies/ 2025-06-20T10:32:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/department-of-health-abu-dhabi-sanofi/ 2025-06-20T08:12:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/cns-innovator-oligonucleotide-licensing/ 2025-06-19T14:47:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-and-us-governments-pursue-contrasting-vaccine-strategies/ 2025-06-19T14:41:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/actio-small-molecule-therapeutics/ 2025-06-19T12:59:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bioorbit-2026-pre-clinical-trials-space-manufactured-protein-crystals/ 2025-06-19T12:44:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-and-eisais-alzheimers-drugs-denied-nhs-use-due-to-high-costs/ 2025-06-19T11:23:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/draig-funding-neuropsychiatric-disorder-therapies/ 2025-06-19T10:35:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-yeztugo-approval-fda/ 2025-06-19T08:24:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-smart-digital-strategies-are-leading-the-way-in-pharmaceutical-manufacturing/ 2025-06-25T10:58:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nhs-england-could-learn-european-health/ 2025-06-18T15:00:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bavarian-nordic-nets-160m-from-priority-review-voucher-sale/ 2025-06-18T14:33:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tisento-melas-treatment/ 2025-06-18T13:17:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-commissioner-envisions-fewer-delays-more-clinical-trial-flexibility-and-ai-use/ 2025-07-16T19:47:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/navigating-tariffs-diplomacy-india-us-pharmaceutical-trade/ 2025-06-18T11:27:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-digital-health-partners-improve-glp1ra/ 2025-06-18T10:54:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/orion-glykos-extend-adc-collaboration/ 2025-06-18T10:33:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-creates-new-priority-review-voucher-scheme-to-boost-us-interests/ 2025-06-18T10:04:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lisata-collaborates-gatc-drug-development/ 2025-06-18T08:39:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genomics-roll-out-predictive-clinical-test-great-britain/ 2025-06-18T08:37:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-lands-bargain-deal-to-acquire-verve-therapeutics-for-1-3bn/ 2025-06-18T09:27:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/ai-powered-orchestration-bringing-the-benefits-to-personalized-therapy/ 2025-06-17T15:52:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/european-companies-scalable-models-succeed-us/ 2025-06-17T14:47:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/averoa-ec-ckd/ 2025-06-17T12:53:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/european-biotech-ecosystem-takes-aim-at-changing-the-funding-narrative/ 2025-06-17T11:03:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ex-acip-panel-warns-of-critically-weakened-us-immunisation-programme/ 2025-06-17T10:32:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/teva-fosun-pharma-tev-56278/ 2025-06-17T10:23:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nextcure-simcere-partner-sim0505/ 2025-06-17T08:34:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/supernus-makes-depression-drug-play-with-795m-sage-buyout/ 2025-06-16T14:43:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/msd-fda-keytruda/ 2025-06-16T12:55:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/eha-2025-astrazeneca-surovatamig-r-r-b-all/ 2025-06-16T11:30:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sarepta-and-roche-halt-dmd-gene-therapys-use-in-certain-patients-after-second-death/ 2025-06-30T08:15:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ethris-thermo-fisher-mrna-solutions/ 2025-06-16T10:42:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/eha-2025-regeneron-lynozyfic-amgen-kyprolis/ 2025-06-16T09:37:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-belantamab-mafodotin-blood-cancer/ 2025-06-16T09:12:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-taps-chinese-biotech-in-5-2bn-chronic-disease-research-deal/ 2025-06-13T15:19:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/myasthenia-gravis-10-3bn-7mm-2034/ 2025-07-09T13:16:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-bharat-biotech/ 2025-06-13T13:42:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/ion-chromatography-and-pharmaceuticals/ 2025-06-16T09:31:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/modernas-mrna-rsv-vaccine-wins-expanded-fda-approval-for-younger-adults/ 2025-06-13T11:14:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/debiopharm-alkyon-radioligand-therapies/ 2025-06-13T10:32:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-abbvie-hcv-therapy/ 2025-06-13T07:28:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biontech-bolsters-mrna-pipeline-with-1-25bn-curevac-acquisition/ 2025-06-12T15:49:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/wes-streeting-29bn-nhs-boost-substantial-but-reform-still-needed/ 2025-06-12T15:53:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vaccine-sceptics-among-new-members-hired-by-rfk-jr-for-cdcs-vaccine-panel/ 2025-06-12T15:41:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/vutrisiran-first-silencer-attr-cm/ 2025-06-12T14:55:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/enterome-eo2463-immunotherapy/ 2025-06-12T14:01:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/customs-simplified-the-need-to-streamline-pharma-shipments/ 2025-06-12T14:01:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-signs-812m-research-deal-with-deep-apple-for-non-glp-1-drugs/ 2025-06-12T10:56:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-capsida-cap-003-gene-therapy-parkinsons/ 2025-06-12T10:47:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/splicebio-gene-therapy/ 2025-06-12T08:07:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-hit-with-fda-clinical-hold-for-batch-of-hiv-trials/ 2025-06-12T12:38:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nhs-to-receive-29bn-funding-boost/ 2025-06-11T15:19:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/echosens-boehringer-partnership-mash-diagnosis/ 2025-06-11T13:59:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/trumps-push-to-onshore-pharma-manufacturing-clouded-by-lack-of-clarity/ 2025-06-11T11:03:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/antares-therapeutics-177m-funding-cancer-medicines/ 2025-06-11T10:35:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/outlook-wet-amd-therapy/ 2025-06-11T08:06:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/odyssey-bails-on-public-listing-as-us-ipo-landscape-stutters/ 2025-06-10T16:04:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mosanna-80m-funding-nasal-spray/ 2025-06-10T13:26:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rfk-jr-axes-vaccine-advisory-committee-members/ 2025-06-10T11:14:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/msd-fda-approval-enflonsia-rsv/ 2025-06-10T11:01:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-alnylam-vutrisiran/ 2025-06-10T08:21:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-clears-yoltech-yolt-101-hefh/ 2025-06-09T14:50:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/podcast-ai-and-supervised-machine-learning-in-clinical-trials-part-2/ 2025-07-01T10:19:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aytu-commercialise-exxua-major-depressive-disorder/ 2025-06-09T10:30:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/american-society-of-clinical-oncology-asco-annual-meeting-2025/ 2025-06-17T16:08:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/european-market-access-lag-2021-2024/ 2025-06-09T09:22:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-astrazeneca-acalabrutinib-combo/ 2025-06-09T07:57:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/schott-pharma-cartridge/ 2025-06-06T13:34:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rfk-jr-looks-to-alter-rare-disease-regulation-by-fast-tracking-drug-approvals/ 2025-06-06T11:54:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/adhd-drugs-back-in-the-spotlight-after-study-debunks-rising-prevalence/ 2025-06-06T10:47:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/juvenescence-ai-drug-discovery-ro5-acquisition/ 2025-06-06T09:49:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-sydnexis-paediatric-myopia/ 2025-06-06T07:54:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dupixent-fuelled-atopic-dermatitis-market-sales-to-hit-22-4bn-by-2033/ 2025-06-05T15:57:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vividion-werner-helicase/ 2025-06-05T13:39:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhra-warns-women-using-weight-loss-jabs-must-use-effective-contraception/ 2025-06-05T12:22:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/akeso-nmpa-approval-cadonilimab/ 2025-06-05T10:35:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/introducing-ai-into-the-pharma-supply-chain-is-a-journey/ 2025-07-03T10:34:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/epro-and-ecoa-digital-solutions-driving-clinical-trials-engagement/ 2025-06-05T09:22:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/axxam-molecular-health/ 2025-06-05T07:45:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ascletis-daily-acne-tablet-set-for-china-review-after-phase-iii-win/ 2025-06-04T15:20:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/redwire-space-cancer-research/ 2025-06-04T13:55:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/agenus-agreements-botensilimab-balstilimab/ 2025-06-04T10:33:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/magazine-are-regulators-keeping-pace-with-ai-adoption-in-clinical-trials/ 2025-06-04T10:18:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-extends-sma-market-lead-with-evrysdi-tablet-approval-in-europe/ 2025-06-04T10:13:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-takeda-hodgkin-lymphoma/ 2025-06-04T07:47:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/asco25-jjs-trispecific-antibody-shows-100-response-in-phase-i-multiple-myeloma-study/ 2025-06-03T19:58:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/asco25-abbvie-flexes-adc-phase-i-data-as-nsclc-market-opportunity-beckons/ 2025-06-04T14:59:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/spyglass-drug-delivery-platform/ 2025-06-03T13:30:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/asco25-kuras-phase-2-ziftomenib-results-trigger-nda-acceptance-from-fda/ 2025-06-03T11:35:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/asco25-genmabs-rina-s-en-route-to-blockbuster-potential-amid-further-positive-data/ 2025-06-03T11:23:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-immunitybio-anktiva/ 2025-06-03T10:27:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/regeneron-hansoh-rights/ 2025-06-03T07:52:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/asco25-amgens-nplate-proves-effective-in-gi-cancer-linked-thrombocytopaenia/ 2025-06-02T16:41:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-outlays-11bn-to-join-biontechs-development-of-bispecific-cancer-drug/ 2025-06-02T15:16:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-blueprint-immunology/ 2025-06-02T13:55:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/asco25-jnjs-carvykti-shows-strong-efficacy-across-multiple-myeloma-risk-groups-2/ 2025-06-02T11:17:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/asco25-regeneron-unpacks-positive-libtayo-data-in-adjuvant-cscc-as-keytruda-stumbles/ 2025-06-02T10:56:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/circode-biomed-clearance-fda-hm2002/ 2025-06-02T10:04:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-regeneron-trials/ 2025-06-02T11:41:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/msd-kras-g12c-drug-early-promise-phase-i/ 2025-06-02T11:18:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/zymeworks-zanidatamab-china/ 2025-06-02T08:33:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/asco25-msd-adc-candidate-achieves-56-3-orr-in-lymphoma-trial/ 2025-05-30T15:54:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/asco25-pfizers-braftovi-combo-boasts-47-drop-in-disease-progression-in-mcrc-2/ 2025-05-30T14:46:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/eyepoint-duravyu-phase-iii-trial/ 2025-05-30T13:54:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alvotech-advanz-biosimilars/ 2025-05-30T13:51:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-rejects-stealth-bios-barth-syndrome-treatment-after-16-5-month-review/ 2025-05-30T10:48:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astellas-evopoint-adc/ 2025-05-30T12:55:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/daiichi-msd-lung-cancer/ 2025-09-29T11:31:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hhs-cancels-766m-bird-flu-vaccine-contract-with-moderna/ 2025-05-29T16:02:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-impact-of-drug-pricing-and-reimbursement-on-the-pharmaceutical-industry/ 2025-06-04T08:13:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/solid-tumours-car-t-therapies/ 2025-05-29T14:49:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/telesis-bio-regeneron/ 2025-05-29T13:05:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/iteos-to-shut-down-following-2bn-gsk-partnered-tigit-asset-failure/ 2025-05-29T11:09:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eton-hydrocortisone-solution/ 2025-05-29T10:12:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-bms-nivolumab-sc/ 2025-05-29T08:00:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-kgaa-seeks-china-us-approval-tgct-drug-phase-iii-success/ 2025-05-29T15:53:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/scynexis-resumes-dosing-in-phase-iii-mario-study-after-lengthy-delay/ 2025-05-28T15:23:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-rmat-abelzeta/ 2025-05-28T13:14:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/4x-the-performance-zero-compromise-how-functionalized-polymers-are-changing-the-rules/ 2025-05-28T13:02:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-3pl-providers-are-gearing-up-for-the-wave-of-cell-and-gene-therapies/ 2025-05-28T11:06:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cdc-drops-covid-19-vaccine-for-healthy-children-and-pregnant-women/ 2025-05-28T10:42:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/glycoera-protein-degrader/ 2025-05-28T10:11:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biogen-city-therapeutics-rnai/ 2025-05-28T08:24:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-the-cell-and-gene-therapy-market-is-taking-shape/ 2025-05-27T16:31:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-to-expand-pain-pipeline-with-1bn-siteone-buyout/ 2025-05-27T16:26:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/capitalising-on-the-uks-goal-to-become-a-world-leading-trial-destination/ 2025-05-27T16:03:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-depemokimab-submission/ 2025-05-27T13:18:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/whats-been-agreed-at-this-years-world-health-assembly/ 2025-05-27T10:53:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lupin-ranibizumab-latin-america/ 2025-05-27T09:24:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-otsuka-igan/ 2025-05-27T07:57:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/excellence-awards/featured-company/2025-upperton-pharma-solutions/ 2025-12-31T15:37:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-soleno-prader-willi/ 2025-05-26T12:17:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-abbisko-hcc/ 2025-05-26T09:18:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chmp-gsk-blenrep/ 2025-05-29T15:30:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/genentech-onshore-us-manufacturing/ 2025-05-23T15:46:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/asco25-roches-itovebi-combo-reduces-risk-of-death-in-breast-cancer-by-33/ 2025-05-23T15:29:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/csl-vifor-sparsentan/ 2025-05-23T13:43:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/obesity-therapies-and-the-multi-indication-momentum-how-industry-is-responding/ 2026-01-19T13:03:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/medicaid-on-a-spit-after-republicans-budget-bill-passes-house-by-single-vote/ 2025-05-23T10:55:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bayer-eylea-set-for-longer-treatment-intervals-to-challenge-roches-vabysmo/ 2025-05-23T10:39:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-gsk-nucala/ 2025-05-23T10:11:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aptar-digital-astrazeneca-algorithms/ 2025-05-23T08:37:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-buys-vigil-neuroscience-for-470m-in-alzheimers-push/ 2025-05-22T15:20:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/paratek-optinose-acquisition/ 2025-05-22T13:57:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/wegovy-and-zepbound-costs-capped-at-200-in-new-evernorth-programme/ 2025-05-22T10:56:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-kisunla-australia/ 2025-05-22T10:10:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/uk-biopharma-innovator-venture-financing-surges/ 2025-05-22T09:59:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/overcoming-cold-chain-logistical-challenges-when-delivering-life-saving-ms-therapies/ 2025-05-22T08:52:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/orionis-genentech-small-molecule-glue-medicines/ 2025-05-22T07:50:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/moderna-shares-down-after-pulling-covid-flu-combo-vaccine-application/ 2025-05-21T14:57:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/can-pharma-tariffs-make-america-manufacture-again/ 2025-05-21T14:28:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/viz-ai-sanofi-regeneron/ 2025-05-21T13:52:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/navigating-new-eu-regulations-in-the-clinical-supply-chain/ 2025-07-01T07:55:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ats-2025-gsk-depemokimab-narrative/ 2025-05-21T11:21:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/who-secures-20-funding-increase-amid-us-shortfall/ 2025-05-21T10:48:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/gsk-strengthens-argument-twice-annual-depemokimab/ 2025-05-21T09:59:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biontech-r-and-d-uk/ 2025-05-21T09:37:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-covid-19-doses/ 2025-05-21T07:57:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hhs-sets-most-favoured-nation-pricing-targets-for-drug-makers/ 2025-05-20T15:28:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/china-mab-adc-licensing-trade-tensions/ 2025-05-20T15:13:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ats-2025-sanofi-regeneron-aim4-trial-personalised-asthma-care/ 2025-05-20T15:12:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ats2025-eti-linked-mucus-clearance-paediatric-cf/ 2025-05-20T12:43:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/skye-arecor-cb1-inhibitor/ 2025-05-20T12:43:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/london-biotechnology-show-makes-grand-return-to-unveil-cutting-edge-advances-in-health-medicine/ 2025-05-20T19:12:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/next%e2%80%91gen-pharma-ai-ml-digital-twins-converge-at-automa-2025/ 2025-05-20T19:14:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/countries-formally-adopt-whos-pandemic-agreement-for-future-pandemics/ 2025-05-20T10:24:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhlw-gsk-blenrep/ 2025-05-20T10:07:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ats2025-anti-il-5-therapy-exacerbations-copd-asthma/ 2025-05-20T09:35:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ats-2025-real-world-data-supports-trikafta-as-gold-standard-in-long-term-cf-care/ 2025-05-20T07:57:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-3sbio-deal/ 2025-05-20T07:37:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/excellence-awards/featured-company/2025-novotech/ 2025-12-31T15:37:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/excellence-awards/excellence-in-focus/novotech-ceo-john-moller-interview/ 2025-05-22T11:56:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/tezepelumab-exacerbation-copd-elevated-eosinophils/ 2025-05-19T16:39:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ats2025-nucala-copd-exacerbations/ 2025-05-19T16:17:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/power-collaboration-pertinent-than-ever-pharma-experts/ 2025-05-19T15:35:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/regeneron-buys-bankrupt-23andme-for-256m/ 2025-05-19T15:25:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/apnimed-sleep-apnoea-pill-phase-iii-success/ 2025-05-19T15:20:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/europe-slow-march-alzheimers-treatments/ 2025-05-19T14:33:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/podcast-ai-and-supervised-machine-learning-in-clinical-trials-ep1/ 2025-07-16T13:22:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/incyte-retifanlimab-combo/ 2025-05-19T12:26:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisks-ceo-to-step-down-as-weight-loss-market-share-plummets/ 2025-05-19T10:23:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-perioperative-opdivo/ 2025-05-19T10:12:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biomarin-inozyme-acquire-270m/ 2025-05-19T07:23:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/excellence-awards/featured-company/2025-imagene/ 2025-12-31T15:37:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-strikes-1-3bn-gene-therapy-deal-with-rznomics/ 2025-05-16T16:23:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/newborn-screening-strategy-needs-modernising-as-hhs-disbands-advisory-committee/ 2025-05-16T19:03:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharmas-ai-prospects-get-nudged-into-the-future-with-eus-ai-act/ 2025-05-19T08:08:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/trump-plan-for-irp-use-via-mfn-executive-order/ 2025-05-16T14:44:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/influence-of-high-energy-milling-on-the-biological-activity-of-microbial-particles/ 2025-05-21T15:19:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amneal-dhe-autoinjector/ 2025-05-16T13:37:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/us-pharma-trump-industry-doubts/ 2025-05-16T13:18:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-biosimilar-approvals-set-for-record-breaking-year-amid-us-pricing-reforms/ 2025-05-16T10:40:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/agc-biologics-quell-cell/ 2025-05-16T09:53:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/next-generation-targeting-for-evolving-hcp-engagement/ 2025-05-21T10:23:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/ai-clinical-trials-regulators-keeping-pace/ 2025-05-16T09:00:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pathos-ai-oncology/ 2025-05-16T07:39:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-awards-cancer-drug-approvals-to-abbvie-and-msd/ 2025-05-15T18:26:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/green-chemistry-navigating-growing-esg-challenges-in-pharma-manufacturing/ 2025-05-15T14:10:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biocryst-orladeyo-hae/ 2025-05-15T12:40:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/excellence-awards/awards/2025-submissions-open/ 2025-06-12T05:11:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-commits-at-least-20bn-to-us-manufacturing-through-2030/ 2025-05-15T10:47:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/engineering-the-future-how-robotics-and-automation-are-transforming-pharmaceutical-logistics/ 2025-05-15T16:51:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-expands-sirna-push-with-335m-adarx-deal/ 2025-05-29T15:31:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kaerus-fragile-x-syndrome/ 2025-05-15T09:27:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/oligonucleotides-the-scottish-research-hub-accelerating-production-scale-up/ 2025-12-08T06:07:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-tempus-cancer/ 2025-05-15T07:48:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-taps-septerna-in-2-2bn-deal-for-oral-obesity-therapies/ 2025-05-14T16:29:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/recipharm-plg-pharma/ 2025-05-14T13:48:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-to-manage-the-complexities-of-synthetic-api-production-in-30-steps/ 2026-02-13T12:12:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-to-spend-2bn-on-phase-iii-liver-disease-drug-acquisition/ 2025-05-14T10:45:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/stylus-medicine-launches-with-85m-to-advance-in-vivo-gene-editing/ 2025-05-14T10:36:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eligo-gene-delivery-platform/ 2025-05-14T10:19:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-iteos-drop-tigit-trial-failure/ 2025-05-14T09:31:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sarepta-gene-therapy-dmd/ 2025-05-14T08:27:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/orphan-drug-market-access-in-europe-hta-challenges-and-the-growing-potential-of-rwe/ 2025-05-13T16:00:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/reducing-patient-burden-in-rare-disease-trials-dcts-for-increased-patient-centricity/ 2025-08-19T11:20:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ensoma-genetic-disorder-treatment/ 2025-05-13T12:36:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-to-transform-ehr-data-into-useful-clinical-insights-using-ai/ 2025-05-13T12:55:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pharma-faces-30-day-deadline-under-trumps-pricing-order/ 2025-05-13T10:55:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-biodexa-fap/ 2025-05-13T10:46:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/republicans-proposed-medicaid-cuts-met-with-dismay/ 2025-05-13T10:37:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abeona-secures-cash-runway-with-155m-priority-review-voucher-sale/ 2025-05-13T10:21:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/glp-1ra-anti-cancer-benefits-beyond-weight-loss/ 2025-05-13T10:19:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhra-astrazeneca-trixeo/ 2025-05-13T08:10:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-plans-700m-manufacturing-plant-in-the-us/ 2025-05-12T16:01:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-growth-hormone-childrens-sogroya/ 2025-05-12T15:47:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/minghui-qilu-mhb088c/ 2025-05-29T15:32:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-advantages-of-isolator-lines-for-large-scale-pharma-manufacturing/ 2025-05-13T11:59:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/trump-to-sign-order-tying-us-drug-prices-to-global-rates/ 2025-05-12T10:58:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lenz-lotus-presbyopia/ 2025-05-12T10:30:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/valnevas-chikungunya-vaccine-use-halted-in-older-adults-amid-safety-concerns/ 2025-05-12T10:21:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-purdue-250m/ 2025-05-12T08:06:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/american-academy-of-neurology-aan-annual-meeting-2025/ 2025-05-13T11:06:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/5eu-q1-2024-versus-2025-pricing-shifts-hta-outcomes/ 2025-05-09T15:23:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hls-esperion-cardiovascular/ 2025-07-08T08:03:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bavarian-nordic-shares-rise-7-following-strong-q1-for-vaccine-sales/ 2025-05-09T10:55:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newbiologix-recipharm-cell-line/ 2025-05-09T10:51:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-chief-martin-makary-sets-june-deadline-for-genai-rollout/ 2025-05-09T10:47:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/haya-heart-failure-treatment/ 2025-05-09T08:26:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/do-not-scrimp-clinical-trial-sanofi-exec-says/ 2025-05-08T16:28:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/viralgen-trogenix-therapy-glioblastoma/ 2025-05-14T11:19:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vc-firm-vivo-capital-outlays-740m-for-biotech-investment/ 2025-05-08T10:43:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biovaxys-sona-cancer/ 2025-05-08T10:23:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ars-pharma-epinephrine-spray/ 2025-05-08T08:06:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-plans-to-expand-unannounced-inspections-of-foreign-drug-plants/ 2025-05-07T14:52:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/europe-understand-us-culture-investment/ 2025-05-07T14:16:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-opus-opgx-lca5/ 2025-05-07T12:51:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-cuts-2025-outlook-due-to-compounding-hit-wegovy-demand/ 2025-05-07T10:43:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sarepta-shares-fall-amid-fdas-cber-appointment-and-weak-elevidys-sales/ 2025-05-07T10:29:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/solve-fshd-armatus/ 2025-05-07T10:08:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/approval-pathways-expediting-challenging-rewarding/ 2025-05-07T10:04:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-calquence-ec/ 2025-05-07T08:13:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/overcoming-challenges-in-orphan-drug-development-from-clinical-trials-to-market/ 2025-08-19T11:25:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-signs-415m-deal-for-alchemabs-als-therapy/ 2025-05-06T15:38:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pharma-ma-deal-value-surges/ 2025-05-06T15:05:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/recursion-axes-drug-programmes-to-streamline-pipeline/ 2025-05-06T14:01:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/veraxa-omniab-adc/ 2025-05-29T15:32:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-government-exercises-144m-option-for-smallpox-mpox-vaccine-contract/ 2025-05-06T11:11:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/glp-1ra-poised-redfine-treatment-paradigm/ 2025-05-06T10:35:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-40bn-us/ 2025-05-06T10:25:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/swiss-biotech-rd-investment-up-2024/ 2025-05-06T08:57:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/teva-alvotech-selarsdi/ 2025-05-06T08:49:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tls-ohio-state-university/ 2025-05-05T13:33:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/innocare-solid-tumour/ 2025-05-05T10:47:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-novo-nordisk-nda/ 2025-05-05T13:33:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pliant-cuts-workforce-by-45-following-lung-trial-termination/ 2025-05-02T15:35:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/q1-earnings-pulse-check-companies-tentative-on-pharma-specific-tariffs/ 2025-05-02T14:07:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bavarian-nordic-chikungunya-vaccine/ 2025-05-02T13:54:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/entering-the-era-of-prenatal-gene-therapies/ 2025-05-06T13:17:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hhs-launches-500m-universal-vaccines-initiative/ 2025-05-02T10:45:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/4dmt-diabetic-macular-oedema/ 2025-05-02T09:52:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ptsd-market-7mm-2034/ 2025-05-02T07:42:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/repare-dcx-agreement/ 2025-05-02T07:27:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biogens-q1-revenue-soars-past-estimates-as-rare-disease-pivot-pays-off/ 2025-05-01T17:08:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lillys-q1-2025-revenue-jumps-45-but-cvs-shift-boosts-novos-wegovy/ 2025-05-01T16:45:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-1bn-cancer-research-hub-planned-for-south-london/ 2025-05-01T15:58:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dimerix-amicus-dmx-200/ 2025-05-01T13:45:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/end-to-end-solutions-why-every-link-in-the-pharmaceutical-supply-chain-counts/ 2025-05-01T13:29:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-remains-resilient-on-tariffs-as-q1-sales-rise-4/ 2025-05-01T10:42:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-regulus-renal-disease/ 2025-05-01T10:27:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-imaavy-fda/ 2025-05-01T09:40:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/investors-insist-halted-biotech-ipos-will-return-in-2025/ 2025-05-01T09:25:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/zejula-mesothelioma-trial-efficacious/ 2025-04-30T17:07:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/biopharma-venture-financing-q1-2025/ 2025-04-30T13:37:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-oxford-cumulus/ 2025-04-30T12:31:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/trumps-first-100-days-tout-us-bound-pharma-investments-amid-tariff-worries/ 2025-04-30T12:35:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/donald-trump-first-100-days-impact-on-the-healthcare-industry/ 2025-05-02T10:24:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/magazine-the-glp-1-shortage-is-over-what-next-for-compounders/ 2025-04-30T11:11:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-abbvie-upadacitinib/ 2025-04-30T10:21:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-abeonas-3-1m-cell-therapy-for-rare-skin-disease/ 2025-04-30T10:17:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/truqap-fails-phase-iii-study/ 2025-04-30T10:18:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/impending-us-tariffs-signal-uncertain-future-global-pharma/ 2025-04-30T09:17:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/msd-biologics-centre-us/ 2025-05-29T15:33:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/us-tariffs-likely-disrupt-drug-development-costs-and-prices/ 2025-04-30T09:19:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/myostatin-inhibitors-target-muscle-loss-prevention-to-fill-gap-in-glp-1ra-market/ 2025-04-29T19:25:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-ceo-calls-for-increased-european-investment-in-pharma/ 2025-04-29T17:27:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/small-biotechs-shoulder-the-burdens-of-an-uncertain-biopharma-sector/ 2025-04-29T14:18:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhra-bridgebio-acoramidis/ 2025-04-29T13:30:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biohaven-secures-600m-financing-as-it-awaits-fda-prodrug-decision/ 2025-04-29T10:06:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/prilenia-ferrer-pridopidine/ 2025-04-29T09:26:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-regeneron-lynozyfic/ 2025-04-29T08:35:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/france-halts-valnevas-chikungunya-vaccine-use-in-seniors/ 2025-04-28T18:21:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-tremfya-ec/ 2025-04-28T13:44:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/innorna-secures-dual-fda-designations-for-wilsons-disease-mrna-therapy/ 2025-04-28T11:05:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-kgaa-strikes-3-9bn-deal-for-springworks/ 2025-05-29T15:33:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgen-ohio-manufacturing/ 2025-04-28T09:37:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-innocare-lymphoma/ 2025-04-28T07:53:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-kgaa-nears-3-5bn-deal-for-springworks/ 2025-05-29T15:34:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-free-to-pursue-semaglutide-compounders-after-latest-court-ruling/ 2025-04-25T16:24:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/akeso-npc-penpulimab/ 2025-04-25T13:16:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/caribou-cuts-pipeline-and-workforce-to-focus-on-lead-car-t-programmes/ 2025-04-30T08:51:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/granite-bio-funding/ 2025-04-25T10:36:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-dyne-dmd/ 2025-05-29T15:39:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/top-20-biopharmas-market-cap-amid-tariff/ 2025-04-24T16:49:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/msds-gardasil-sales-slide-further-due-to-china-constraints/ 2025-04-24T16:18:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/challenges-in-filling-for-alum-drug-products-what-does-a-cdmo-need-to-successfully-fill-alum-drug-products/ 2025-06-30T16:33:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/thermo-fisher-counters-tariffs-with-2bn-investment-into-us-manufacturing/ 2025-04-24T17:01:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pharmaceutical-europe-us/ 2025-04-24T23:00:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-enters-200m-ai-cancer-pact-with-tempus-and-pathos/ 2025-04-24T10:33:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/repertoire-genentech-therapies/ 2025-04-24T10:13:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biogen-friedreichs-ataxia/ 2025-04-24T07:54:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-sues-mochi-health-and-others-for-deceptive-tirzepatide-marketing/ 2025-05-23T15:22:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/veraxa-to-go-public-in-1-6bn-spac-deal-with-voyager/ 2025-05-29T15:40:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/synthetic-hormones-future-contraception/ 2025-04-23T15:11:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/editco-promega-technologies-deal/ 2025-04-23T14:26:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/fda-layoffs-and-priority-review-voucher-programmes-lapse-disrupt-rare-disease-pipeline/ 2025-04-23T21:38:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-to-expand-oncology-presence-with-572m-tessellate-bio-deal/ 2025-05-29T15:40:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/concertai-bayer-oncology/ 2025-04-23T10:04:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tnf-renova-health/ 2025-04-23T08:22:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/first-two-medicinal-products-eu-jcas/ 2025-04-22T16:39:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/fso-vs-fps-cpo-highlights-key-considerations-for-your-decision/ 2025-10-08T11:48:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fujifilm-regeneron-manufacturing/ 2025-04-22T13:25:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/spotlight-on-hepatitis-b-new-report-examines-the-diseases-clinical-trial-landscape-in-2025/ 2025-04-22T13:45:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/daan-gc-cell/ 2025-04-30T08:48:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kkr-offers-1-2bn-to-buy-swedish-life-sciences-group-biotage/ 2025-04-24T23:02:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-us-investment/ 2025-04-24T23:05:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-uniqure-huntingtons/ 2025-04-21T11:54:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhra-gsk-blenrep/ 2025-04-21T10:28:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-regeneron-dupilumab/ 2025-04-23T04:38:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-and-bighat-biosciences-ink-ai-antibody-discovery-deal/ 2025-05-29T15:00:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-orforglipron-first-phase-iii-win/ 2025-04-17T15:19:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/regeneron-aflibercept-8mg/ 2025-04-17T13:25:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bluebird-bio-reaffirms-carlyle-deal-as-ayrmid-misses-deadline/ 2025-04-17T10:51:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/big-pharma-pushes-for-european-policy-change-as-tariffs-loom/ 2025-04-21T09:23:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/neurelis-nasal-spray-fda/ 2025-04-17T09:48:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/acip-gsk-rsv-vaccine/ 2025-04-17T07:34:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/trump-order-eases-medicare-price-negotiation-for-small-molecule-drugs/ 2025-04-16T20:28:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/glycomine-raises-115m-to-advance-rare-disease-therapy-into-phase-iib/ 2025-04-17T10:27:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/who-member-states-agree-on-treaty-to-fight-future-pandemics/ 2025-04-16T18:31:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/podcast-tariffs-editorial-team-discuss/ 2025-08-12T17:53:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-glp-1-drug-shortage-is-over-whats-next-for-the-compounders/ 2025-04-17T16:34:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eisai-biogen-lecanemab/ 2025-04-16T12:46:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/3-reasons-why-biotechs-preparing-for-launch-need-a-compliant-content-foundation/ 2025-04-25T14:17:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mural-shuts-down-lead-programme-and-slashes-90-of-staff/ 2025-04-16T10:32:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/irish-pharmaceutical-exports/ 2025-04-16T13:59:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/the-7mm-atopic-dermatitis-market-to-experience-growth-reaching-22-4bn-by-2033/ 2025-04-16T09:25:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-cue-develop-autoimmune/ 2025-05-29T15:00:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-projects-400m-tariff-hit-but-raises-sales-outlook/ 2025-04-16T05:33:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-camzyos-nhcm-phase-iii-failure/ 2025-04-15T17:49:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/in-vivo-car-t-cell-therapies-potential-overtake-ex-vivo/ 2025-04-15T15:23:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/escmid-2025-climate-infectious-disease-risk/ 2025-04-15T14:56:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/coherus-divests-udenyca-franchise/ 2025-04-15T12:44:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-collaborative-partnerships-are-driving-progress-in-transformative-cell-and-gene-therapies-cgts/ 2025-04-15T16:30:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ironwoods-shares-sink-as-fda-demands-new-trial-for-lead-drug/ 2025-04-15T10:12:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/valneva-chikungunya-vaccine-brazil/ 2025-04-15T10:10:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/risk-of-tariff-triggered-global-recession-growing-globaldata/ 2025-04-15T13:46:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/reveal-ona-ona-255/ 2025-05-29T14:59:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/verves-shares-jump-by-more-than-26-on-lilly-partnered-gene-therapy-data/ 2025-04-14T19:15:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-drops-obesity-pill-liver-issue/ 2025-04-14T15:46:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/copd-market-projection-2033/ 2025-04-14T12:42:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-columvi-combo-dlbcl/ 2025-04-14T12:14:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/scancell-shares-up-6-after-nhs-partnership-for-fast-track-cancer-vaccine-trial/ 2025-04-14T10:50:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kyowa-kirin-facility-japan/ 2025-04-14T10:19:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sandoz-challenges-amgens-enbrel-patents-in-us-antitrust-lawsuit/ 2025-04-14T16:26:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-opdivo-approved-us/ 2025-04-14T07:32:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-commits-23bn-to-us-manufacturing-amid-tariff-threats/ 2025-04-16T21:26:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pluri-immune-cell-technologies/ 2025-04-11T13:38:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-to-phase-out-animal-testing-with-ai-and-lab-based-models/ 2025-04-11T10:50:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazenecas-oral-breast-cancer-drug-truqap-greenlit-for-nhs-use/ 2025-04-11T10:40:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bbm-takeda-haemophilia-b/ 2025-04-11T10:26:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/can-ai-replace-medical-writers-experts-say-not-immediately-2/ 2025-04-11T19:51:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biocon-biologics-bevacizumab/ 2025-04-11T08:05:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/keros-therapeutics-considers-sale-amid-investor-pressure/ 2025-04-10T15:58:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cingulate-grant-anxiety-treatment/ 2025-04-10T13:16:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tempest-hits-funding-block-for-phase-iii-liver-cancer-drug-in-waiting/ 2025-04-10T11:01:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhra-reconfirmed-as-who-biologics-partner-amid-us-withdrawal/ 2025-04-10T10:42:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/resign-or-be-fired-apha-executive-director-calls-out-rfk-jr/ 2025-04-10T10:24:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/aan-2025-long-term-data-mg-guide-treatment-standards/ 2025-04-10T10:02:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pharmalogic-agilera-acquisition/ 2025-04-10T09:44:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/b-braun-system-antibiotics/ 2025-04-10T07:45:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merida-launches-with-121m-to-target-autoimmune-antibodies/ 2025-04-09T15:04:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/ira-holds-the-scope-to-shape-pharmas-research-strategy-say-experts/ 2025-04-09T14:34:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/beyond-oncology-the-expanding-potential-of-cell-and-gene-therapies/ 2025-04-09T16:43:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/60-degrees-yale-babesiosis/ 2025-04-09T13:14:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pharma-ceos-warn-ec-president-of-risk-of-exodus-to-us/ 2025-04-16T21:26:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-outlays-1-09bn-to-boost-glp-1ra-production-in-brazil/ 2025-04-09T10:57:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/trump-tariffs-pharmaceutical-imports/ 2025-04-16T14:03:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/obesity-related-liver-conditions-understanding-treatment-options/ 2025-04-09T14:02:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-upadacitinib-authorisation-gca-eu/ 2025-04-09T08:02:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/epsilogen-acquires-tigatx-to-expand-pan-isotope-cancer-antibody-pipeline/ 2025-04-08T14:12:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kalvista-hae-kaken-japan/ 2025-04-08T13:27:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-gov-investment-health-data-service/ 2025-04-08T10:55:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eu-president-to-meet-pharma-leaders-as-tariff-threat-looms/ 2025-04-16T21:25:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ethris-lonza-mrna-vaccines/ 2025-04-08T09:17:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/africa-the-clinical-impact-of-the-us-withdrawal-from-who-and-usaid/ 2025-07-15T11:02:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-approval-darzalex/ 2025-04-08T07:50:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ad-pd-2025-leqembi-operational-challenges-safety/ 2025-04-08T06:52:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rfk-jr-shifts-stance-on-mmr-vaccine-amid-measles-deaths/ 2025-04-07T16:53:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ad-pd-2025-first-real-world-data-report-leqembi-focuses-operational-challenges/ 2025-04-07T15:58:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rhythm-seeks-market-expansion-imcivree-phase-iii-victory/ 2025-04-07T16:20:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nmpa-santen-glaucoma-treatment/ 2025-04-07T12:28:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/obesity-drugs-wont-be-covered-by-medicare-under-2026-cms-policy/ 2025-04-07T10:13:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazenecas-imfinzi-combo-ec/ 2025-04-07T09:37:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abl-gsk-neurodegenerative/ 2025-04-07T07:25:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/uveitis-market-1-5bn-7mm-2033/ 2025-04-04T15:38:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-daiichi-astrazeneca-enhertu/ 2025-05-29T14:58:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fear-and-uncertainty-linger-over-fda-future-in-wake-of-trump-admin-layoffs/ 2025-04-04T11:48:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/wes-streeting-promises-uk-pharma-quick-action-on-vpag-frustration/ 2025-04-04T10:11:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nbe-adc-facility-switzerland/ 2025-05-29T14:58:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/digital-cognitive-assessments-and-blood-based-biomarkers-in-alzheimers-research/ 2025-04-04T08:55:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofis-rilzabrutinib-fda/ 2025-04-04T07:51:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/neurona-raises-102m-to-advance-cell-therapy-for-drug-resistant-epilepsy/ 2025-04-03T15:45:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/io360-summit-car-t-cell-therapy-manufacture/ 2025-04-03T15:40:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ad-pd-2025-dhts-disease-progression-early-parkinsons/ 2025-04-03T15:22:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abpi-calls-on-uk-government-to-resolve-vpag-crisis/ 2025-04-03T13:43:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/atsena-150m-gene-therapy/ 2025-04-03T13:32:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/io360-car-t-cell-therapy-beyond-blood-cancer/ 2025-04-04T14:24:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pharma-industry-dodges-tariff-blow-but-still-braces-for-disruption/ 2025-04-16T21:23:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/weight-loss-implants-compliance-admin-burden/ 2025-04-03T11:12:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-novartis-vanrafia-igan/ 2025-04-03T09:03:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/thin-layer-chromatography-and-high-performance-liquid-chromatography-in-herbal-drug-analysis/ 2025-04-03T09:54:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astellas-jfcr-oncology-research/ 2025-04-03T08:12:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-life-sciences-venture-capital-funding-lags-behind/ 2025-04-02T16:11:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-uncertainty-weighs-on-ipo-market-while-uk-innovation-could-benefit/ 2025-04-02T15:56:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/acc-2025-glp-1ras-af-flutter-diabetic-patients/ 2025-04-02T15:40:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/organon-us-rights-biogen/ 2025-04-02T13:01:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rfk-jr-swings-axe-at-us-health-agencies/ 2025-04-02T10:54:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/airna-secures-155m-to-bring-rna-candidate-to-clinic/ 2025-04-02T10:04:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amneal-shilpa-boruzu-us/ 2025-04-02T10:02:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/apellis-empaveli-snda/ 2025-04-02T07:55:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/acc-25-tirzepatide-influences-clinical-trajectory-of-patients-with-hfpef-and-obesity/ 2025-04-01T20:40:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/magazine-are-european-biopharma-manufacturers-nearshoring/ 2025-04-01T16:56:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/cns-market-resurgence/ 2025-04-01T15:40:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/judge-rejects-jjs-9bn-talc-settlement-for-third-time/ 2025-04-01T14:53:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/reshoring-us-fmcg-business/ 2025-04-01T14:44:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/platform-trials-the-challenges-benefits-and-best-practices-to-maximize-results-with-an-edc-platform/ 2025-05-27T16:45:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bioversys-patent-bv100/ 2025-04-01T13:55:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-bavarian-nordic-freeze-dried-mpox-and-smallpox-vaccine/ 2025-04-01T13:00:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-will-ai-shape-the-future-of-the-nhs/ 2025-04-01T12:13:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/large-pharma-drug-licensing-china-2024/ 2025-04-01T11:36:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizers-rsv-vaccine-wins-expanded-approval-in-eu-gaining-edge-over-gsk/ 2025-04-01T10:31:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/nhs-england-abolished-bold-cure-risky-operation/ 2025-04-01T09:46:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/apollomics-launxp-nsclc/ 2025-04-01T08:49:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-astrazeneca-imfinzi-combo/ 2025-04-01T07:27:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/excellence-awards/featured-company/2025-northwest-ehealth-nweh/ 2025-12-31T15:38:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/acc-2025-imbrias-ninerafaxstat-data-shows-potential-for-cardiometabolic-hfpef/ 2025-04-01T02:20:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/google-backed-isomorphic-labs-raises-600m-to-advance-ai-drug-discovery/ 2025-03-31T16:30:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ukraine-cost-containment-retail-drug-market/ 2025-04-01T10:09:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/cell-and-gene-therapy-collections-the-need-for-consistency/ 2025-03-31T14:46:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofis-qfitlia-approved-by-fda-as-first-haemophilia-therapy-for-all-patients/ 2025-03-31T13:55:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/biopharma-ipos-recovery-2024/ 2025-03-31T10:56:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vertex-halts-development-of-diabetes-cell-therapy-after-trial-failure/ 2025-03-31T10:35:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/interviews/saving-shelved-ultra-rare-therapies-through-unorthodox-funding/ 2025-06-09T16:18:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/acc-25-oral-semaglutide-t2d/ 2025-03-31T09:15:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-strikes-1bn-deal-for-lexicons-oral-obesity-drug/ 2025-03-28T16:04:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/macau-iaso-mm-therapy/ 2025-03-28T14:25:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/msd-subcutaneous-keytruda-non-inferior-to-iv-version-of-blockbuster-drug/ 2025-03-28T12:02:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/weill-cancer-hub-east/ 2025-03-28T10:39:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/10000-jobs-cut-us-healthcare-agencies/ 2025-04-02T16:29:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genmabs-tivdak-japan/ 2025-05-29T14:58:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/soleno-wins-fda-approval-for-prader-willi-hyperphagia-treatment/ 2025-03-27T18:40:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hhs-announces-major-workforce-cuts-and-reorganisation/ 2025-03-27T18:37:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-bioconjugation-is-unlocking-the-next-generation-of-drug-development/ 2025-03-27T16:04:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ionis-sobi-olezarsen-commercialisation/ 2025-03-27T14:33:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/blockbuster-potential-drugs-ruled-the-2024-pipeline-with-53-rise-over-2023/ 2025-03-27T11:55:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/aga-overhauls-uc-treatment-pathway/ 2025-03-27T11:30:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tribune-scar-tissue-therapies/ 2025-03-27T10:31:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/msd-ec-approval-vaccine-capvaxive/ 2025-04-25T16:59:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/eu-health-data-space-strikes-a-chord-in-eu-harmonisation-plans/ 2025-04-01T15:11:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/unmatched-quality-in-pharmaceutical-logistics-why-it-matters/ 2025-03-26T16:24:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-gsk-blujepa/ 2025-05-29T14:57:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/big-pharma-faces-headwinds-in-china-as-vaccine-sales-decline/ 2025-03-26T14:06:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhra-launches-new-monthly-safety-bulletins/ 2025-03-26T14:07:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-fast-tracks-sanofis-mrna-vaccine-for-chlamydia/ 2025-03-26T11:15:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cassava-calls-time-simufilam-alzheimers/ 2025-03-26T14:06:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/character-biosciences-eye-disease-therapies/ 2025-03-26T10:10:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/msd-hengrui-lpa-inhibitor/ 2025-03-26T08:31:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-and-uk-researchers-plan-to-study-shingrix-and-dementia-risk-reduction-link/ 2025-03-25T19:24:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-earmarks-2bn-for-chinese-triple-g-weight-loss-shot/ 2025-03-25T15:02:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alumis-kaken-esk-001/ 2025-03-25T13:51:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/wuxi-apptec-annual-results-show-foreign-contracts-continue/ 2025-03-27T21:29:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/overcoming-regulatory-challenges-in-sterile-manufacturing/ 2025-03-25T14:56:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ukhsa-unveils-high-risk-pathogen-list-to-drive-innovation/ 2025-03-25T11:41:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/trump-tariffs-pharma-manufacturing/ 2025-06-19T22:04:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-gsk-nucala-copd/ 2025-03-25T10:31:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sermonix-regor-breast-cancer/ 2025-03-25T08:13:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/digital-health-therapeutics-pharma/ 2025-03-28T11:21:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tempero-secures-70m-to-advance-addiction-treatment-candidate/ 2025-03-24T17:59:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/valneva-outlays-40000-vaccines-to-reunion-amidst-chikungunya-surge/ 2025-03-24T17:41:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alberta-siemens-cancer-foundation/ 2025-03-24T12:51:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/tuberculosis-sirtuo-resistance-research/ 2025-03-24T14:35:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/augustine-secures-85m-to-advance-charcot-marie-tooth-candidate/ 2025-03-24T11:30:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-everest-cancer-vaccine/ 2025-03-24T13:38:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-2-5bn-china/ 2025-03-24T08:20:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-boosts-us-operations-with-55bn-investment/ 2025-03-21T17:23:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alnylam-challenges-pfizer-and-bridgebio-with-fda-nod-for-attr-cm-drug/ 2025-03-21T17:04:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/mastering-compliance-and-copyright-in-healthcare-and-medcomms/ 2025-04-23T10:44:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-hutchmed-tazverik-fl/ 2025-03-21T14:07:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/european-agencies-catch-up-with-speedier-regulatory-pathways-for-cgts-in-the-us/ 2025-03-21T12:23:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/global-funding-cuts-reversing-decades-of-tuberculosis-progress-who-says/ 2025-03-21T11:35:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-to-manage-regulatory-complexities-with-clinical-trial-data/ 2025-03-21T11:24:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/menarini-bpdcn-visualdx/ 2025-03-21T10:16:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-fda-tremfya-crohns/ 2025-03-21T08:20:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-outlays-1-9bn-to-purchase-dren-bios-bispecific-antibody/ 2025-03-20T16:35:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/servier-black-diamond-deal/ 2025-03-20T13:43:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/international-reference-pricing-irp-2024/ 2025-03-21T15:07:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-alzheimer-drug-could-prevent-onset/ 2025-03-20T11:48:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-haleon-3-3bn/ 2025-03-24T09:51:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/oxford-roche-cancer-treatments/ 2025-05-29T14:46:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/blood-cancers-car-t-pipeline/ 2025-03-20T08:11:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/allogeneic-cell-therapies-poised-for-prime-time-says-expert/ 2025-03-21T02:03:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uspto-patents-remedy-lhi/ 2025-03-19T14:52:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sacklers-to-pay-up-to-7bn-in-purdue-pharmas-opioid-settlement-plan/ 2025-03-19T19:23:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/insight-insitro-ai-model/ 2025-03-19T10:47:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/arbor-gene-editing-treatments/ 2025-03-19T08:28:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/opko-entera-oral-treatment-metabolic-disorders/ 2025-03-18T14:37:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/curevo-procures-110m-and-former-gsk-exec-for-shingles-vaccine-candidate/ 2025-03-18T11:39:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/health-canada-biogen-skyclarys/ 2025-03-18T10:35:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/big-tech-meets-biotech-recursion-ai-gold-rush-pharma/ 2025-03-18T09:49:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-alteogen-platform-technology/ 2025-03-18T08:32:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/investigating-key-strategies-for-optimising-clinical-trial-supply-chains-in-2025/ 2025-03-18T16:29:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/latigo-non-opioid-pain-treatment/ 2025-03-17T13:54:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/clinical-trial-challenges-china-sharp-clinschain/ 2025-07-03T10:32:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/taiho-outlays-1-14bn-to-acquire-adc-specialist-araris/ 2025-03-17T11:53:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/azurity-covis-pharma/ 2025-03-17T10:35:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bristol-myers-squibb-fl-therapy/ 2025-03-19T12:30:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/unsafe-and-unregulated-cell-therapies-being-sold-in-europe/ 2025-03-19T12:31:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-director-says-ai-must-be-a-thought-partner-in-drug-discovery/ 2025-03-14T16:29:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-salipro-drug-discovery/ 2025-03-14T15:17:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/meiragtx-and-hologen-launch-ai-backed-gene-therapy-venture/ 2025-03-14T11:28:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-otsuka-lundbeck-rxulti/ 2025-03-14T10:42:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/insilico-110m-drug-ai/ 2025-03-14T08:56:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gedeon-richters-once-daily-endometriosis-pill-approved-for-nhs-use/ 2025-03-13T19:52:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mallinckrodt-and-endo-sign-6-7bn-merger-deal/ 2025-03-13T19:21:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vivani-treats-first-patient-with-long-lasting-drug-implant-for-weight-loss/ 2025-03-13T16:07:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/emergent-agreement-swiss-rockets/ 2025-03-13T14:01:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/telixs-new-lead-212-generator-could-dispel-medical-isotope-scalability-hurdles/ 2025-03-13T11:34:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vivace-35m-cancer-drug-vt3989/ 2025-03-13T11:12:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/atsena-atsn-201-xlrs/ 2025-03-13T08:28:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/orphelia-explores-avenues-for-liquid-neuroblastoma-med-after-eu-chmp-rejection/ 2025-03-12T19:56:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ono-earmarks-940m-to-gain-rare-blood-cancer-therapy-from-ionis/ 2025-05-29T13:42:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/envirotainer-expands-cold-chain-solutions-portfolio-to-cover-all-pharma-segments-sizes-and-temperatures/ 2025-03-12T14:43:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vori-health-53m-musculoskeletal/ 2025-03-12T14:33:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/zealand-and-roche-strike-5-3bn-obesity-treatment-deal/ 2025-03-12T11:13:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/entos-investment-rd-facility/ 2025-03-12T10:40:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/wuxi-xdc-abtis-antibody-drug-conjugates/ 2025-03-12T09:04:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-to-acquire-longtime-cell-therapy-partner-2seventy-bio-for-286m/ 2025-03-11T20:57:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/viking-strikes-150m-deal-to-secure-supply-of-obesity-drug/ 2025-03-11T19:58:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/msd-new-1bn-facility/ 2025-03-11T14:05:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lundbeck-amlenetug-japan-msa/ 2025-03-11T13:47:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/elevatebio-taps-amazons-genai-tools-to-design-crispr-therapeutics/ 2025-03-11T11:36:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/amid-deglobalising-trade-experts-seek-ai-safeguards-for-clinical-trial-supply/ 2025-03-11T10:34:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kenox-lactiga-siga-therapies/ 2025-03-11T08:27:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-and-ionis-win-eu-approval-for-attr-polyneuropathy/ 2025-03-10T22:18:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vaccinex-plans-nasdaq-exit-as-alzheimer-market-pressure-grows/ 2025-03-10T20:15:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/artificial-intelligence-is-making-clinical-supply-chains-more-efficient-and-more-sustainable-heres-how/ 2025-03-10T17:24:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ia-2a-positivity-t1d-progression/ 2025-03-10T14:47:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-genentech-boston-hub/ 2025-05-29T13:31:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alliance-pharma-agrees-to-362m-acquisition-by-dbay/ 2025-03-10T11:50:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-bms-opdivo-yervoy/ 2025-03-10T11:32:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sun-pharma-checkpoint/ 2025-03-10T10:42:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uks-pricing-watchdog-rejects-alzheimer-treatments-for-the-second-time/ 2025-03-07T17:09:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/johnson-johnson-mdd-trial-failure-termination/ 2025-03-07T16:33:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/scpharmaceuticals-furoscix-snda-fda/ 2025-03-07T14:59:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/the-trillion-dollar-opportunity-in-womens-health/ 2025-03-07T11:50:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-odd-injectable-radiotherapy/ 2025-03-07T11:33:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/understanding-the-rules-on-hpapi-containment-in-high-potent-manufacturing/ 2025-03-10T13:35:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astellas-yaskawa-jv-cell-therapy/ 2025-04-22T12:44:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tumour-on-chip-model-could-help-discover-pancreatic-cancer-therapies/ 2025-03-06T19:13:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merckkgaa-reports-2024-earnings-amid-ongoing-springworks-acquisition-talks/ 2025-03-06T22:26:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/itm-targets-us-approval-for-radiopharmaceutical-after-phase-iii-readout/ 2025-03-06T21:46:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/project-optimus-the-evolution-of-dose-optimisation-in-oncology/ 2025-03-06T17:59:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tris-pharma-eyes-approval-trial-success/ 2025-03-06T16:21:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tc-biopharm-ophthalmic-company/ 2025-03-06T14:30:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-cuts-wegovy-price-through-new-direct-to-patient-online-pharmacy/ 2025-03-06T12:13:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/trimtech-31m-cns-therapeutics/ 2025-03-06T10:52:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/beyond-compliance-the-strategic-role-of-pass-in-rare-disease-therapy-success/ 2025-03-06T14:21:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/realising-the-opportunities-for-growth-in-the-european-orphan-drug-market/ 2025-03-06T14:18:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/orphan-drugs-stock-losses-europe/ 2025-03-07T11:26:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-ars-neffy-1mg/ 2025-03-06T09:27:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biosimilars-drive-sandoz-growth-ahead-of-unclear-tariff-effects-in-2025/ 2025-03-05T17:59:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jazz-pharmaceuticals-bids-for-chimerix-in-935m-deal/ 2025-03-05T17:03:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/container-closure-integrity-testing-ccit-what-you-need-to-know/ 2025-07-03T10:18:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/indonesia-antengene-xpovio/ 2025-03-05T15:15:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/asceneuron-halts-alzheimers-trial-adding-to-tau-targeting-setbacks/ 2025-03-05T11:58:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/wuxi-e-coli-expression/ 2025-03-05T11:27:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/mwc-barcelona-2025-maximizing-5g-network-value-in-the-age-of-ai/ 2025-03-05T09:58:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-beigene-tevimbra-oesophageal-cancer/ 2025-03-05T08:55:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/antibody-drug-conjugates-adc-tackling-the-unsolved-challenges/ 2025-03-04T17:07:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/callio-her2-dual-payload-adc/ 2025-03-04T19:56:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/are-european-biopharma-manufacturers-nearshoring/ 2025-03-05T10:36:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/machine-learning-adoption-into-supply-chain-management-on-the-horizon-2/ 2025-03-04T13:24:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/reflecting-on-a-milestone-year-for-cell-and-gene-therapies/ 2025-03-04T12:36:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genentech-wins-fda-approval-for-second-stroke-treatment/ 2025-03-04T11:50:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazenecas-imfinzi-chemo-nsclc/ 2025-03-04T10:50:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/mwc-barcelona-2025-huawei-unveils-global-showcases-alongside-customers-and-launches-10-industry-solutions-with-partners-2/ 2025-03-04T10:59:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nuvation-bio-taletrectinib/ 2025-03-04T09:11:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/artificial-intelligence-enhance-regenerative-medicine/ 2025-03-03T17:03:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-and-ai-driven-gensaic-enter-into-354m-cardiometabolic-deal/ 2025-03-03T16:25:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-bavarian-nordic-vaccine/ 2025-03-03T15:21:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ryoncil-first-fda-approved-msc-therapy/ 2025-03-03T14:57:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-enters-obesity-space-with-2-3bn-gubra-deal/ 2025-03-03T11:52:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/top-ai-companies-pharma/ 2025-11-05T11:42:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bridgebio-oncology-helix/ 2025-03-03T11:16:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/magnet-lilly-molecular-glue/ 2025-03-03T09:07:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/inborn-errors-of-metabolism-elicit-unique-challenges-for-therapy-development/ 2025-03-07T14:04:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/driving-bioscience-innovation-how-teesside-university-empowers-industrybreakthroughs/ 2025-03-04T08:59:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chmp-abbvie-rinvoq-gca/ 2025-02-28T14:39:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rare-disease-treatments-skipping-uk-patients-largely-due-to-costs-survey-shows/ 2025-02-28T11:32:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/medigene-epimab-tce/ 2025-02-28T10:35:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/why-pharma-is-still-far-from-a-treatment-for-galactosemia/ 2025-02-28T11:35:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-sobi-gamifant/ 2025-02-28T09:10:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/exelixis-future-growth-cosmic-313-trial-challenges/ 2025-02-28T08:33:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alltrna-plans-to-tackle-rare-diseases-using-trna-based-therapies/ 2025-02-28T02:37:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/zevra-sells-priority-review-voucher-for-150m-to-support-drug-launches/ 2025-02-27T22:16:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-eu-trial-regulations-to-expedite-approvals-and-address-shortages/ 2025-02-27T21:10:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-ma-activity-down-in-january-amid-uncertain-us-opportunities/ 2025-02-27T20:44:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mandatory-drug-stock-monitoring-empowers-eu-to-tackle-shortages/ 2025-02-27T20:30:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/scope-2025-ai-clinical-operations/ 2025-02-27T16:04:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pfizers-bet-gene-therapies-haemophilia-bust/ 2025-02-27T15:58:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/vietnam-foreign-investment-restrictions-amended-pharmaceutical-law/ 2025-02-27T15:35:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ipa-ribopro-mrna/ 2025-02-27T14:16:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/nice-approval-casgevy-sickle-cell-disease-uk/ 2025-02-27T11:42:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/regeneron-makes-second-bid-for-blood-cancer-therapy-approval/ 2025-02-27T11:24:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-pyxis-pyx-201/ 2025-03-03T10:35:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-pharma-manufacturing-new-sites/ 2025-02-27T08:27:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/magazine-radiopharmaceutical-deals-drive-sector-growth-despite-supply-crisis/ 2025-02-26T17:54:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eikon-raises-almost-351m-to-advance-cancer-candidates-through-the-clinic/ 2025-02-26T17:40:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/emalex-eyes-fda-approval-for-tourette-syndrome-therapy-after-phase-iii-success/ 2025-02-26T17:41:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/idorsias-tryvio-deal-collapses-forcing-company-to-find-cash-urgently/ 2025-02-26T16:03:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/fda-approvals-decline-drug-innovation-remains-strong/ 2025-02-26T14:59:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/redhill-hyloris-bekinda/ 2025-02-26T14:36:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/usaid-sponsors-agencies-foundations-fill-funding-gap/ 2025-03-05T14:26:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-pays-10m-upfront-for-organovo-fxr-agonist/ 2025-02-26T11:38:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-grin-radiprodil/ 2025-02-26T10:41:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-sarclisa-mm/ 2025-02-26T08:27:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/supply-chain-uncertainties-present-opportunities-for-biopharma-couriers-in-2025/ 2025-02-25T23:31:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-broadens-its-deal-with-bridgene-for-up-to-770m/ 2025-02-27T13:16:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jandj-sues-samsung-bioepis-over-surreptitious-breach-of-stelara-biosimilar-contract/ 2025-02-25T22:42:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-removes-clinical-hold-on-entradas-duchenne-therapy/ 2025-02-25T17:06:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-takeda-takhzyro-hae/ 2025-02-25T14:10:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-lenacapavir-hiv-ema/ 2025-02-25T11:05:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/sionna-therapeutics-ipo-strategic-shift-cf-market/ 2025-02-25T10:26:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-bms-opdivo-yervoy/ 2025-02-25T08:31:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/digital-genocide-bmj-post-alleges-patient-data-deletion-amid-dei-purge/ 2025-02-25T11:38:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-sets-sights-on-summits-bispecific-in-combo-with-its-adcs/ 2025-02-25T10:34:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/celltrion-avtozma-ec/ 2025-02-24T13:51:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/transforming-manufacturing-and-packaging-at-pharmap-2025/ 2025-02-24T13:28:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/semaglutide-shortage-ends-as-fda-sets-deadline-for-compounders/ 2025-03-26T19:40:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/meiragtx-seeks-uk-approval-after-gene-therapy-restores-sight-in-children-born-blind/ 2025-02-24T11:30:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/teva-alvotech-ustekinumab-biosimilar/ 2025-02-24T10:38:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mirum-ctexli-fda-ctx/ 2025-02-24T08:47:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/struggling-bluebird-bio-to-go-private-for-less-than-30m/ 2025-02-26T10:34:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-shelves-haemophilia-gene-therapy-beqvez-amid-low-demand/ 2025-02-21T16:28:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/urogen-iconovir-oncolytic-virus/ 2025-02-21T14:54:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/glp-1ras-oud-treatment/ 2025-02-21T13:27:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-cns-researchers-are-handling-clinical-trial-turbulence/ 2025-02-24T09:39:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-green-lights-two-blood-cancer-therapies-for-nhs-use/ 2025-02-21T11:32:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/incyte-genesis-small-molecule-medicines/ 2025-02-21T11:20:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/navigating-the-complexities-of-sustainable-specialty-pharma-supply-chains/ 2025-02-24T11:19:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/csl-behring-andembry-japan/ 2025-02-21T08:53:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fibrogen-sells-china-unit-to-astrazeneca-for-160m/ 2025-02-20T20:02:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/zealand-pharma-steadfastly-upholds-amylin-based-obesity-drug-strategy/ 2025-02-20T19:47:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/oct-west-coast-recruitment-regulation-key-pain-points/ 2025-03-05T14:28:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/x4-taiba-deal-whim/ 2025-02-20T14:56:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/key-pharma-launch-trends-2024/ 2025-02-20T12:13:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/who-targets-over-half-a-million-children-in-gaza-for-polio-vaccine-drive/ 2025-02-20T11:45:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/immunitybio-fda-bcg-alternative/ 2025-02-20T11:07:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pharma-medtech-reacts-us-health-job-cuts/ 2025-02-20T10:57:26+00:00 daily 0.2